WEBINARS
Our webinars allow users to learn from experts and earn continuing education credits on industry topics, progress in research, services available, and more.
Show More
-
JAN 23, 2020 | 9:00 AM
DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST... -
JAN 22, 2020 | 9:00 AM
DATE: January 22, 2019TIME: 9:00am PST, 12:00pm EST I describe the essentials for pursuing research grants from private foundations and corporations. Specifically, I revi...
-
JAN 15, 2020 | 10:00 AM
DATE: January 15, 2020 TIME: 10:00am PST Genomics, personalized medicine and cost stewardship are just a few of the forces behind the need for better management of discrete testing informati...
-
JAN 14, 2020 | 4:00 PM
DATE: January 15, 2020 9:00am JST, January 14, 2020, 4:00pm PST, 7:00pm EST...
-
JAN 14, 2020 | 9:00 AM
Fecal elastase-1 – a biomarker for pancreatic exocrine insufficiency(EPI) continues to gain traction as an ideal biomarker for assessing EPI. This presentation will include a review of...
-
JAN 14, 2020 | 8:00 AM
DATE: January 14, 2019 TIME: 8:00am PST Drug-induced QT interval prolongation and Torsades de Pointes (TdP) arrhythmias are the leading causes for drug withdrawals from market and compound a...
-
JAN 09, 2020 | 10:00 AM
Join us on January 9, 2020 for this live webinar!...
-
JAN 01, 2020 | 6:00 AM
With an increasing push to improve safety, efficacy, and efficiency throughout the drug development pipeline, researchers are evermore looking to improve the predictive capacity of their in...
JAN 01, 2020 | 6:00 AM
The liver plays a critical role in the metabolism and clearance of more than 70% of marketed drugs. Furthermore, toxicity to the liver is a major reason for preclinical and clinical drug fai...
JAN 01, 2020 | 6:00 AM
“The poor translatability of early-stage preclinical models is a major setback in oncology drug development. Immortalized cell lines, that are extensively used in drug screens, undergo...
JAN 01, 2020 | 6:00 AM
Misfolded and accumulated neurodegenerative disease associated proteins (NDAPs, such as tau and alpha-synuclein) represent the major pathological hallmark in Alzheimer’s and Parkinson&...
